Skip to content
Close
SEARCH
CONTACT US
CONTACT US

OUR SERVICES

We take a personalized and integrated approach to help our clients position their pipelines and companies for success offering a full range of development and commercialization services.

VIEW ALL SERVICES
PHASES
DISCOVERY
Uncover breakthrough
innovations during the drug
discovery phase.
CLINICAL DEVELOPMENT
Advance through clinical
development and health
authority review with confidence.
ALL STAGES
Benefit from our expertise
across all phases
of drug development.
PRECLINICAL
Navigate the critical
preclinical testing phase
with expert guidance.
COMMERCIALIZATION
Successfully bring your
product to market with
our commercialization support.
ALL SERVICES
Access comprehensive
services for every stage
of product development.

ABOUT US

We are Halloran, a life science consulting firm, partnering to enrich your product development and business growth. We propel your organization further; positively impacting the health and wellbeing of patients around the world.

LEARN MORE ABOUT US
EXPERTISE WITH PERSONALITY
OUR FOUNDER
Discover the visionary
leader driving Halloran's
success and innovation.
STRATEGIC PARTNERS
Meet our trusted
strategic partners who
enhance our capabilities.
WHY HALLORAN?
Explore the unique reasons
why clients choose
Halloran for their needs.
OUR TEAM
Get to know the dedicated
professionals who make
up the Halloran team.
CAREERS
Join our dynamic team
and advance your
career with Halloran.
CASE STUDIES
Learn Halloran’s unique
strategy and approach to address
the pressing needs of our clients.
hcg-service-hero-1

Events

 

 

UPCOMING EVENTS

At Halloran Consulting Group, building a strong, vibrant community is central to our mission. Our events, whether in person or virtual, embody this commitment, fostering connections, sharing knowledge, and driving innovation within the life science industry.
These gatherings, ranging from intimate roundtable discussions to large-scale conferences, bring together thought leaders, innovators, and professionals to engage in dynamic discussions and form lasting connections. By participating in our events, you will gain valuable insights and contribute to a collaborative community dedicated to advancing the life science industry.
Cell & Gene The Podcast
Read More
Cell & Gene: The PodcastBridging Development and Regulation in CGT with Halloran Consulting Group's Monika Swietlicka

On this podcast, Monika Swietlicka, Principal Consultant, explores key regulatory hurdles in cell and gene therapy, from FDA demands to the rising role of real-world evidence.

Read More
Cell & Gene The Podcast
Read More
Cell & Gene: The PodcastDefining Product Roles and Navigating FDA Approval with Halloran Consulting Group's Monika Swietlicka

Episode 2 of FDA Fridays features Halloran’s Monika Swietlicka sharing strategies for navigating FDA regulation in cell and gene therapy—from defining a therapy’s role early, to investing in CMC, addressing surrogate endpoints, and integrating commercial considerations for long-term success.

Read More
DPHARM
Read More
Philadelphia, PADPHARM: Disruptive Innovations to Modernize Clinical Trials

TUES, SEPTEMBER 16 - WEDS, SEPTEMBER 17, 2025 

 

Read More
CORE
Read More
San Diego, CACORE

MON, OCTOBER 6 - WED, OCTOBER 8, 2025 

 

Read More
MassBio Align Summit 2025
Read More
Boston, MAMassBio Align Summit 2025

TUES, OCTOBER 7, 2025

Read More
ISPE
Read More
Charlotte, NCISPE Annual Meeting & Expo 2025

OCTOBER 26-27, 2025

 

Read More
ISPE
Read More
Bay Area, CaliforniaBiocom CEO/Founder Network: Roadmap to a Successful Series A

OCTOBER 30, 2025

 

Read More
CNS Summit
Read More
Boston, MACNS Summit

SUN, NOVEMBER 2 - WEDS, NOVEMBER 5, 2025 

 

Read More
AMWA
Read More
Phoenix, AZMedical Writing & Communication Conference

WEDS, NOVEMBER 5, - SAT, NOVEMBER 8, 2025 

 

Read More
CBSA Awards 2025
Read More
Denver, COColorado BioScience Association's 22nd Annual Awards Celebration

THURS, NOVEMBER 13, 2025

 

Read More
Converge Biocom
Read More
San Francisco, CAConverge Meet-Up, Biocom California

THURS, OCT. 16, 2025

 

Read More